Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Acurx Pharmaceuticals, Inc. (ACXP) had Stock-Based Compensation of $0.60M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.25M |
|
-- |
|
-- |
|
$2.31M |
|
$-2.31M |
|
$0.05M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.31M |
|
$-2.31M |
|
4.26M |
|
4.26M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$10.98M |
|
-- |
|
-- |
|
$10.98M |
|
$2.83M |
|
-- |
|
-- |
|
$2.83M |
|
$8.15M |
|
$8.15M |
|
$8.15M |
|
4.68M |
|
| Cash Flow Statement Financials | |
$-3.12M |
|
-- |
|
$6.22M |
|
$7.56M |
|
$10.66M |
|
$3.10M |
|
|
Stock-Based Compensation |
$0.60M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.65% |
|
-27.65% |
|
-20.52% |
|
-27.65% |
|
$1.74 |
|
$-0.73 |
|
$-0.73 |
|